Collectively, these results show that the TGFβ-induced self-renewal capacity of BCSCs in breast cancer is dependent of COX-2 expression and activity, and highlight a novel function for COX-2 and its metabolite PGE2 in regulating cancer stemness downstream of TGFβ signaling. The gene discussed is TGFB1; the disease is breast cancer.